Peng Li

19PUBLICATIONS
76CO-AUTHORS
Predictive and prognostic markersMolecular targetsNeural engineeringEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 26, 2026
FUS inactivation promotes leptomeningeal metastasis of lung cancer through the up-regulation of CD36.

|Aug 13, 2026
Integrin β6-Targeted CAR-T Cells exhibit potent antitumor activity in β6-Positive pancreatic ductal adenocarcinoma and lung adenocarcinoma.

|Dec 30, 2025
PDZRN4 suppresses lung adenocarcinoma progression via inhibiting ubiquitin-mediated HIF-1A degradation.

Honghao Li, Junfeng Wu, Hua Dai

|Sep 08, 2025
RELA Ablation Contributes to Progression of Hepatocellular Carcinoma with TP53R249S Mutation and is a Potential Therapeutic Target.

Zhiping Wu, Zhe Wang, Diwei Zheng

|Mar 21, 2025
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity.

Yao Li, Jiongliang Wang, Linfu Zhou

|Sep 22, 2023
BCL11B and the NuRD complex cooperatively guard T-cell fate and inhibit OPA1-mediated mitochondrial fusion in T cells.

Rui Liao, Yi Wu, Le Qin

Pageof 4

Frequent Collaborators

4 joint publications

Yao Yao

4 joint publications

Yangqiu Li

3 joint publications

Zhiping Wu

3 joint publications

Duanqing Pei